Introduction
Angiotensin II (Ang II) is a key hormone in the regulation of blood pressure. In addition to its vascular effects, Ang II has direct effects on renal tubular functions. In particular, Ang II acts on sodium and bicarbonate absorption from the proximal tubules, and this process is thought to have a significant impact on body fluid and sodium homeostasis ( 1 -3 ). There are two distinct features of the effects of Ang II on renal proximal tubules. First, proximal tubular fluid contains high concentrations of Ang II, which cannot be explained by simple spillover from the systemic circulation ( 4 ) . In fact, proximal tubular cells have all the components to locally generate Ang II, which, after being secreted into proximal tubular lumen, may exert paracrine/autocrine effects ( 5 , 6 ) . Second, Ang II regulates renal proximal tubule transport in a biphasic manner that features stimulation by low (picomolar to nanomolar) concentrations of Ang II and inhibition by high (nanomolar to micromolar) concentrations of Ang II ( 1 , 2 , 7 ). Although conflicting data have been reported regarding the identity of the receptor subtype(s) that mediates this unique mode of regulation ( 7 -9 ), our data from Ang II type 1 receptor (AT 1 )-deficient mice have clearly shown that AT 1 mediates both stimulatory and inhibitory effects of Ang II (10, 11) . Our recent study further revealed that the extracellular signal-regulated kinase (ERK) pathway mediates only the stimulatory effect of Ang II, whereas the group IV cytosolic phospholipase A2 (cPLA2-α)/P450 pathway mediates the inhibitory effect of Ang II independently of ERK (12) . Arachidonic acid, released by cPLA2-α, is in turn metabolized by cytochrome P450 epoxygenase in renal proximal tubules, and the final metabolite 5,6-epoxyeicosatrienoic acid (EET) seems to be responsible for the inhibitory effect of Ang II (13) .
Unexpectedly, our data also suggested that the cPLA2-α/ P450 pathway might work to prevent ERK activation by Ang II in intact proximal tubules (12) . Indeed, high concentrations of Ang II failed to activate ERK in wild-type mice. However, when the cPLA2-α activity was abrogated by pharmacological means or genetic knockout, high concentrations of Ang II activated ERK. This finding is quite surprising, because P450 metabolites are reported to activate ERK in a number of different types of cells such as endothelial cells, arterial smooth muscle cells, glomerular mesangial cells, and renal tubular epithelial cells (14, 15) . In vascular smooth muscle cells, for example, hydroxyeicosatetraenoic acid (HETE) is believed to mediate ERK activation by Ang II (16) . These seemingly contradictory results suggest the possibility that P450 metabolites may exert a unique inhibitory effect on Ang II-induced ERK activation in intact proximal tubules. In this study, we directly tested this hypothesis by investigating the effects of Ang II in the presence of arachidonic acid or its metabolite, 5,6-EET. In view of the multiplicity of Ang II-mediated signaling cascades, as well as the diversity of P450 metabolitemediated biological actions, we used isolated proximal tubules from wild-type, AT1A-deficient, and cPLA2-α-deficient mice.
Methods

Animals
Male AT1A-deficient (17) and cPLA2-α-deficient mice (18), 5 to 8 weeks old, were used in the present study. These mice had been backcrossed to C57B6 for more than 9 generations. Moreover, we confirmed that their littermates that expressed normal alleles for AT1A and cPLA2-α exhibited transport capacities of the renal proximal tubules that were similar to those recorded in wild-type C57B6 mice. Therefore, we used normal C57B6 mice for the wild-type controls instead of the littermates. All the mice were provided with standard food and water at libitum. All animal procedures were in accordance with local institutional guidelines.
Measurements of Na-HCO3 Cotransporter Activity
Na-HCO3 cotransporter (NBC) activity was determined as previously described (10, 12) . Briefly, the proximal tubule (S2 segment) fragment was microdissected manually and transferred to a perfusion chamber mounted on an inverted microscope, and both ends of the tubule were sucked into two holding pipettes. To avoid the influence of luminal transporters, the luminally-collapsed tubule was used. The tubule was incubated with 15 μmol/L of an acetoxymethyl ester form of a pH sensitive fluorescence dye known as 2′,7′-bis(carboxyethyl)-5(6)-carboxyfluorescein (BCECF; Dojindo, Kumamoto, Japan) for 5 min at room temperature. Intracellular pH (pHi) was monitored with a photometry system (OSP-10; Olympus, Tokyo, Japan). To achieve a rapid exchange of experimental solution, the chamber was perfused at a rate of 10 mL/min with prewarmed (38°C) perfusate equilibrated with 5% CO2/95% O2 gas. Dulbecco's modified Eagle's tissue culture medium (DMEM) was used for the peritubular perfusate, which was shown to be essential for the long-term functional preservation of isolated proximal tubules (10, 11, 19) . The intracellular buffer capacity was determined by monitoring the pHi changes that accompanied sudden alterations in the bath CO2 tension. Bath HCO3 − concentrations were repeatedly reduced from 25 to 12.5 mmol/L in the absence and presence of Ang II. The rate of pHi decrease to bath HCO3 − reduction and the buffer capacity were used to calculate the NBC activity as described (10, 11, 19) . Ang II, arachidonic acid, and ketoconazole were obtained from Sigma (St. Louis, USA). 5,6-EET was from Cayman Chemical (Ann Arbor, USA), and recombinant human epidermal growth factor (EGF) was purchased from Upstate Biotechnology (Lake Placis, USA). 5,6-EET and ketoconazole were dissolved in ethanol, and Ang II and arachidonic acid were dissolved in H2O.
Measurements of the Rate of Bicarbonate Absorption
To measure the rate of bicarbonate absorption (JHCO3 − ), we used the stop-flow microspectrofluorometric method, which has been shown to be appropriate for both rabbit and mouse proximal tubules (11, 12, 20) . Proximal tubules were microperfused according to the method previously described (11, 12, 20) , and luminal pH (pHL) was monitored on the OSP-10 system. The tubular lumen was perfused with Ringer's solution, which contained 25 mmol/L HCO3 − , 40 mmol/L raffinose and BCECF, whereas DMEM was used for bath perfusate. To determine JHCO3 − , the rapid (~80 nL/min) luminal perfusion was abruptly stopped by suddenly reducing the perfusion pressure from ~18 to 0 cmH2O. The decay in luminal HCO3 − concentration was calculated from the changes in pHL, and JHCO3 − was calculated as described (20) .
When the perfusion pressure is suddenly reduced to zero upon stop-flow, the tubular lumen tends to partially collapse. A correction for this volume loss into the pipettes was performed using the decaying 440 nm (pH-insensitive) fluorescence signals as a marker of the residual luminal volume as described (20) .
Measurements of Intracellular Ca 2+ Concentrations
Intracellular Ca 2+ concentrations were measured as previously described (10) . Briefly, the tubules were incubated with 30 μmol/L Fura-2/AM (Dojindo) for 60 min in DMEM under 5% CO2/95% O2 gas. Thereafter, the tubule was transferred into the perfusion chamber and sucked into two holding pipettes, and intracellular Ca 2+ signals were measured on the OSP-10 system. The calibration curves were calculated at the end of each experiment, and intracellular Ca 2+ concentrations were derived according to the method proposed by Grynkiewicz et al. (21) .
Analysis of ERK Phosphorylation
ERK phosphorylation was analyzed as previously described (12) . Briefly, thin slices of kidney cortex were obtained from mice. They were divided into segments of small bundles, consisting mostly of proximal tubules as described (12) . These samples were incubated at 37°C for 40 min in DMEM under 5% CO2, which contained an angiotensin converting enzyme inhibitor captoril (0.1 μmol/L; Sigma) to suppress the endogenous production of Ang II. After Ang II was added for 2 min, the samples were homogenized in an ice-cold buffer (25 mmol/L Tris-HCl, pH 7.4, 10 mmol/L sodium orthovanadate, 10 mmol/L sodium pyrophosphate, 100 mmol/L sodium fluoride, 10 mmol/L EDTA, 10 mmol/L EGTA, and 1 mmol/L phenylmethylsulfonyl fluoride) and centrifuged. Equal amounts (~20 μg) of protein samples were obtained from the supernatants, separated by SDS-PAGE, and transferred to a nitrocellulose membrane. The membrane was incubated with anti-ERK or anti-phospho-ERK antibodies (Cell Signaling Technology, Beverly, USA) and then with horseradish peroxidase-conjugated anti-rabbit IgG. The signals were detected by an ECL Plus system (Amersham, Aylesbury, UK), and Scion Image (Scion Corporation, Frederick, USA) was used to perform densitometric analysis.
Statistics
The data were represented as mean values ±SEM. Significant differences were determined by applying the paired or unpaired t-test or ANOVA with Bonferroni's adjustment as appropriate.
Results
Effects of Ang II in Wild-Type Mice
To clarify the roles of arachidonic acid metabolites in Ang II signaling in proximal tubules, we focused on the regulation of NBC, which is one of the main target transporters of Ang II (10, 11) . In wild-type mice, Ang II regulates NBC activity in a biphasic manner, which is exclusively mediated by AT1A (10, 12) . Therefore, we first examined the effects of arachidonic acid or 5,6-EET in inhibiting the effects of Ang II. As shown in Fig. 1A, 10 − 6 mol/L Ang II inhibited NBC activity.
Incubation with arachidonic acid or with 5,6-EET for more than 20 min significantly reduced the baseline NBC activity (p< 0.01 by ANOVA), as reported (12) . Moreover, the inhibitory effect of Ang II was lost in tubules preincubated with arachidonic acid or 5,6-EET. (12, 13) . As previously reported (10), 10 − 8 mol/L Ang II did not affect the basal NBC activity.
We confirmed that 10 − 8 mol/L Ang II also did not affect the NBC activity in the presence of arachidonic acid or 5,6-EET (data not shown).
We subsequently examined the impact of arachidonic acid or 5,6-EET on the stimulatory effects of Ang II. As shown in Fig. 1B, 10 − 10 mol/L Ang II stimulated the NBC activity, but this stimulation was again lost in tubules preincubated with arachidonic acid or 5,6-EET. Because the stimulatory effect of Ang II was dependent on ERK activation (12), we examined the Ang II-induced ERK phosphorylation. Ang II was applied for 2 min, the protocol of which was shown to induce a maximal ERK phosphorylation in tissues of the renal cortex (12) . As shown in Fig. 2A and B, 10 − 10 mol/L Ang II stimulated the ERK phosphorylation as reported (12) . However, arachidonic acid or 5,6-EET markedly suppressed Ang IIinduced ERK phosphorylation without changing the basal ERK phosphorylation. These results are consistent with the hypothesis that arachidonic acid and its metabolites suppress the AT1A-mediated stimulation of NBC activity by preventing ERK activation. On the other hand, neither arachidonic acid nor 5,6-EET impacted the EGF-induced ERK phosphorylation, as shown in Fig. 2C and D. This result suggests that arachidonic acid metabolites do not exhibit general inhibitory effects on agonist-mediated ERK activation, but they do have a specific inhibitory effect on Ang II-mediated ERK activation.
Effects of Ang II in AT1A-Deficient Mice
In AT1A-deficient mice, low concentrations of Ang II fail to activate the NBC activity because of a very low level of expression of AT1B. Instead, only 10 − 6 mol/L Ang II stimulates the NBC activity through the AT1B/ERK-pathway (10, 12) . Therefore, we examined the effects of 10 − 6 mol/L Ang II Fig. 3A , both arachidonic acid and 5,6-EET significantly reduced the baseline NBC activity (p< 0.05 by ANOVA). In addition, the stimulatory effect of 10 − 6 mol/L Ang II on NBC activity was lost in the presence of arachidonic acid or 5,6-EET. As shown in Fig. 3B , arachidonic acid and 5,6-EET suppressed the Ang II-induced ERK phosphorylation, without changing the basal ERK phosphorylation. Our results indicate that arachidonic acid and its metabolites also suppress the AT1B-mediated stimulation of NBC activity by preventing the ERK activation.
Effects of Ang II in cPLA2--Deficient Mice
The aforementioned results indicate that the inhibitory effect of arachidonic acid and its metabolites on Ang II-mediated ERK activation is independent of AT 1 subtypes. On the other hand, several types of signaling cross-talk exist between cPLA 2 and ERK ( 16 , 22 ) . To avoid the influence of such interactions, we examined the effects of Ang II in cPLA 2 -α -deficient mice. In cPLA 2 -α -deficient mice, more than 10 Fig. 2B. through the ERK pathway ( 12 ) . Therefore, cPLA 2 -α is considered the cPLA 2 isoform that is responsible for the inhibitory effect of Ang II. We examined the effect of 10 − 6 mol/L Ang II in these mice. As shown in Fig. 4A , arachidonic acid or 5,6-EET significantly reduced the baseline NBC activity ( p < 0.01 by ANOVA) as reported ( 12 ) . More importantly, the stimulatory effect of 10 − 6 mol/L Ang II on NBC activity was completely lost in the presence of arachidonic acid or 5,6-EET. As shown in Fig. 4B and C, arachidonic acid and 5,6-EET again suppressed the Ang II-induced ERK phosphorylation without changing basal ERK phosphorylation. These results indicate that arachidonic acid and its metabolites can suppress the Ang II-mediated stimulation of NBC activity by preventing the ERK activation, even in the absence of cPLA 2 -α activity.
Effects of Ang II on J HCO 3 -
The results obtained to date with respect to the regulation of NBC activity suggest that arachidonic acid and its metabolites can attenuate the stimulatory effects of Ang II on net proximal tubule transport. To test this hypothesis, we measured J HCO 3 − in wild-type mice using the stop-flow microspectrofluorometric method ( 20 ) . 
Roles of Cell Ca
2+
Ang II is generally considered to increase cell Ca 2+ concentrations through the phospholipase C/inositol-tris-phosphate pathway ( 23 ) . Douglas and colleagues, however, reported different mechanisms for cell Ca 2+ increase. On the basis of data obtained from cultured rabbit proximal tubular cells, they proposed that Ang II-induced Ca 2+ increases in proximal tubules arise secondary to the release of arachidonic acid and the production of 5,6-EET ( 24 ) . To test whether a similar mechanism operates in intact proximal tubules, we measured cell Ca 2+ concentrations in wild-type mice. As shown in Fig.  6A , the addition of 10 − 7 mol/L 5,6-EET did not increase cell Ca 2+ , although the addition of 10 − 6 mol/L Ang II induced a typical spike-like cell Ca 2+ increase. In 7 tubules, we could not detect a significant cellular Ca 2+ increase following addition of 5,6-EET. Similarly, we also failed to detect a significant cell Ca 2+ increase in the presence of 10 − 7 mol/L arachidonic acid ( n = 8). On the other hand, Douglas and colleagues also reported that incubating a cell culture with arachidonic acid significantly enhances the Ang II-induced cell Ca 2+ increase ( 24 ) . As shown in Fig. 6B , however, incubating with 10 − 7 mol/L arachidonic acid for up to 10 min did not enhance the cell Ca 2+ response to Ang II ( n = 5). These results do not support the role of arachidonic acid metabolites as the mediator of Ang II-induced cell Ca 2+ increase in intact proximal tubules.
Discussion
We previously showed that although the ERK pathway mediates only the stimulatory effect of Ang II, the cPLA 2 -α /P450 pathway mediates the inhibitory effect of Ang II independently of ERK in renal proximal tubules ( 12 ) . In the absence of cPLA 2 -α or P450 activities, however, the ERK activation by high concentrations of Ang II was unmasked, suggesting that P450 metabolites might also work to suppress the Ang IImediated ERK activation ( 12) . In the present study we directly tested this hypothesis by examining the effects of Ang II on NBC activity or net bicarbonate transport in the presence of arachidonic acid or 5,6-EET. Our results in wildtype mice are consistent with a view that arachidonic acid and its metabolites not only mediate the inhibitory effect of Ang II as previously reported (7, (10) (11) (12) (13) , but also suppress the Ang II-mediated stimulation of NBC activity by preventing the ERK activation. Furthermore, this inhibitory effect on ERK activation was preserved in both AT1A-deficient and cPLA2-α-deficient mice. From these observations, we conclude that the inhibitory effect of arachidonic acid and its metabolites on Ang II-induced ERK activation is independent of AT1 subtypes or cPLA2-α activities and should be attributed to the intrinsic properties of intact proximal tubules.
As in various previous studies (10-12), we did not find significant differences in the basal NBC activity in wild-type, AT1A-deficient, or cPLA2-α-deficient mice. Our results suggest that the basal NBC activity is independent of AT1A or cPLA2-α, at least under our experimental conditions. However, proximal tubules from these mice showed different responses to high concentrations of Ang II. As previously reported (10), we confirmed that the repeated addition of Ang II, separated by sufficient wash-out periods, induced similar cell Ca 2+ increases in individual proximal tubules. This observation suggests that short-term incubation with Ang II may not significantly change the membrane expression level of AT1A. We also note that incubation with captoril might not completely suppress the endogenous production of Ang II in renal cortex tissues. Theoretically, such residual Ang II production in renal cortex tissues would significantly shift the concentration dependency of Ang II-mediated ERK activation. However, the concentration dependence of Ang IIinduced ERK activation in renal cortex tissues was identical to the concentration dependence of Ang II-induced NBC stimulation in isolated proximal tubules (10) (11) (12) . The endogenous production of Ang II was negligible under our experimental conditions. These observations strongly suggest that the residual endogenous production of Ang II, if non-negligi- We speculate that different experimental methods using radioisotope-labeled arachidonic acid on cultured proximal tubules would be required to precisely measure these concentrations. 5,6-EET is reported to increase cell Ca 2+ concentrations in several tissues including pituitary or parotid cells (25, 26) . Douglas and colleagues, on the basis of observations in cultured proximal tubular cells, even proposed that arachidonic acid metabolites might mediate the Ang II-induced cell Ca 2+ increase (24) . However, our study shows that arachidonic acid metabolites are unlikely to mediate the Ang II-induced cell Ca 2+ increase in intact proximal tubules. Our conclusion is consistent with our previous observation that the Ang IIinduced cell Ca 2+ response is preserved in proximal tubules isolated from cPLA2-α-deficient mice (12) .
Several models have been proposed that link G-proteincoupled receptors to the ERK cascade (27) . They include Rasdependent ERK activation via transactivation of receptor tyrosine kinases or Ras-independent ERK activation via protein kinase C. Depending on cell types, P450 metabolites of arachidonic acid may be also involved in ERK activation. Muthalif et al., for example, identified a key role of HETE in Ang II-mediated ERK activation in vascular smooth muscle cells (16) . They showed that the stimulation of cPLA2 by Ang II or by norepinephrine facilitates arachidonic acid release. P450 metabolites of arachidonic acid, such as 12,15-HETE or 20-HETE, activate ERK by the Ras/Raf/mitogen-activated protein kinase (MEK) pathway. Activation of MEK/ERK in turn amplifies cPLA2 activity and further releases arachidonic acid concentrations.
In sharp contrast to such a positive feedback loop between the cPLA2/P450/HETE pathway and the ERK cascade in vascular smooth muscle cells, our study indicates that the cPLA2-α/P450/EET pathway operates as a negative feedback loop with respect to the ERK cascade in renal proximal tubules. Moreover, the cPLA2-α/P450/EET pathway may not exhibit a general inhibitory effect on agonist-mediated ERK activation, but may instead exert a specific inhibitory effect on Ang IImediated ERK activation. At present the exact molecular mechanism underlying the contrasting effects of cPLA2/P450 pathway on the ERK cascade in vascular smooth muscle cells and in renal proximal tubules remains unknown. To date, we have not established whether the Ras/Raf family is indeed involved in the Ang II-mediated ERK activation in intact renal proximal tubules. In all likelihood, different approaches using the dominant negative forms of Ras and/or Raf on cultured proximal tubular cells would be necessary to clarify this issue. On the other hand, the P450-eicosanoids are known to activate a variety of intracellular signaling pathways, some of which may be mediated by a putative cell surface receptor or by direct intracellular interactions (15) . From a teleological viewpoint, however, it is tempting to speculate that renal proximal tubules may have to develop the unique mechanism to attenuate the excessive activity of Ang II. Indeed, in situ proximal tubular fluid is reported to contain high concentrations of Ang II (4), and uncontrolled Ang II actions may result in problematic events such as cell hypertrophy or tissue damage (28, 29) . Activation of ERK by EET has been reported in cultured proximal tubular cells (30) . However, we previously failed to detect any significant ERK phosphorylation by 5,6-EET in renal cortex tissues of both wild-type and cPLA2-α-deficient mice (12) . In addition, the negative effects of EET on ERK activation shown in our study are more consistent with a protective role of EET in Ang II-induced renal injury, as previously reported in rats that overexpress the human renin and angiotensinogen genes (28) . Interestingly, several EET members are known to exhibit antihypertensive properties and they are therefore potential therapeutic targets (31) . It is possible that the negative effect on the ERK cascade in intact proximal tubules may play a role in the antihypertensive properties of EET, because the ERK activation is coupled to the stimulation of proximal transport (12) . Figure 7 summarizes our working hypothesis regarding the biphasic regulation of proximal tubule transport by Ang II. In our model, the Ang II-mediated stimulation is dependent on the MEK/ERK pathway. In contrast, the Ang II-mediated inhibition is dependent on the cPLA2-α/P450/EET pathway, but not on the MEK/ERK pathway. Indeed, other researchers have shown that the pharmacological inhibition of the MEK/ ERK pathway does not impact basal NBC activity (12) . However, the cPLA2-α/P450/EET pathway also works to suppress Ang II-mediated ERK activation. At present, the precise mechanism by which the cPLA2-α/P450/EET pathway exerts negative effects on the Ang II-mediated ERK activation is unknown. However, one possible mechanism would be the involvement of several phosphatases, which are known to negatively regulate ERK pathway activity (32) .
In summary, our results show that the cPLA2-α/P450/EET pathway has a distinct negative effect on Ang II-induced ERK activation in intact proximal tubules. This effect operates not only to suppress the stimulatory effect of Ang II, but it also to explain the antihypertensive properties of EET.
